United States

Grow bone with
the new MagnetOsTM MIS

Engineered for precise delivery and predictable fusions

Close

MagnetOs Clinical Whitepaper

Use of a Novel Biphasic Calcium Phosphate with Submicron Surface Topography as an Extender to Autograft in Posterolateral Spinal Fusion

Introduction: This whitepaper from the University of California, San Diego details the use of MagnetOs Putty used on-label as a bone graft extender in two challenging revision cases. Both subjects had predictable fusions and reduction in pain scores postoperatively.

Conclusion: This case series review demonstrates the efficacy of MagnetOs as an extender to autograft in a retrospective cohort of patients undergoing posterolateral fusion.

Disclaimer: Results from in vitro or in vivo laboratory testing may not be predictive of clinical experience in humans. Please refer to the Instructions for Use for a full list of indications, contraindications, precautions and warnings. For important safety and intended use information please visit kurosbio.com/eifu. MagnetOs is not cleared by the FDA or TGA as an osteoinductive bone graft.

PROMO_MAG_US_124-21_R02